• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群对类风湿关节炎疾病修饰抗风湿药物治疗效果影响的研究进展。

Advances in the implications of the gut microbiota on the treatment efficacy of disease-modifying anti-rheumatic drugs in rheumatoid arthritis.

机构信息

Department of Rheumatology, Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Department of Rheumatology, Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China.

出版信息

Front Immunol. 2023 Sep 28;14:1189036. doi: 10.3389/fimmu.2023.1189036. eCollection 2023.

DOI:10.3389/fimmu.2023.1189036
PMID:37841256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10568326/
Abstract

Alterations in the composition or function of the gut microbiota are associated with the etiology of human diseases. Drug-microbiota interactions can affect drug bioavailability, effectiveness, and toxicity through various routes. For instance, the direct effect of microbial enzymes on drugs can either boost or diminish their efficacy. Thus, considering its wide range of metabolic capabilities, the gut microbiota is a promising target for pharmacological modulation. Furthermore, drugs can alter the microbiota and the mechanisms by which they interact with their host. Individual variances in microbial profiles can also contribute to the different host responses to various drugs. However, the influence of interactions between the gut microbiota and drugs on treatment efficacy remains poorly elucidated. In this review, we will discuss the impact of microbiota dysbiosis in the pathogenesis of rheumatoid arthritis (RA), and we will attempt to elucidate the crosstalk between the gut microbiota and disease-modifying anti-rheumatic drugs (DMARDs), with an emphasis on how drug-microbiota interactions affect the treatment efficacy in RA. We speculate that improved knowledge of these critical interactions will facilitate the development of novel therapeutic options that use microbial markers for predicting or optimizing treatment outcomes.

摘要

肠道微生物组的组成或功能的改变与人类疾病的病因有关。药物-微生物组相互作用可以通过多种途径影响药物的生物利用度、疗效和毒性。例如,微生物酶对药物的直接作用可以增强或减弱其疗效。因此,考虑到其广泛的代谢能力,肠道微生物组是一个有前途的药理学调节靶点。此外,药物可以改变微生物组及其与宿主相互作用的机制。微生物谱的个体差异也可能导致宿主对各种药物的不同反应。然而,肠道微生物组和药物之间的相互作用对治疗效果的影响仍不清楚。在这篇综述中,我们将讨论肠道微生物组失调在类风湿关节炎(RA)发病机制中的作用,并试图阐明肠道微生物组与改善病情的抗风湿药物(DMARDs)之间的相互作用,重点讨论药物-微生物组相互作用如何影响 RA 的治疗效果。我们推测,对这些关键相互作用的深入了解将有助于开发新的治疗选择,利用微生物标志物来预测或优化治疗结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/424a/10568326/8d0029a704fd/fimmu-14-1189036-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/424a/10568326/8d0029a704fd/fimmu-14-1189036-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/424a/10568326/8d0029a704fd/fimmu-14-1189036-g001.jpg

相似文献

1
Advances in the implications of the gut microbiota on the treatment efficacy of disease-modifying anti-rheumatic drugs in rheumatoid arthritis.肠道微生物群对类风湿关节炎疾病修饰抗风湿药物治疗效果影响的研究进展。
Front Immunol. 2023 Sep 28;14:1189036. doi: 10.3389/fimmu.2023.1189036. eCollection 2023.
2
DMARDs-Gut Microbiota Feedback: Implications in the Response to Therapy.DMARDs-肠道微生物群反馈:对治疗反应的影响。
Biomolecules. 2020 Oct 24;10(11):1479. doi: 10.3390/biom10111479.
3
Factors associated with the composition of the gut microbiome in patients with established rheumatoid arthritis and its value for predicting treatment responses.与已确诊类风湿关节炎患者肠道微生物组组成相关的因素及其对预测治疗反应的价值。
Arthritis Res Ther. 2023 Mar 2;25(1):32. doi: 10.1186/s13075-023-03013-x.
4
Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities.肠道微生物群与类风湿关节炎:从发病机制到新的治疗机会。
Front Immunol. 2022 Sep 8;13:1007165. doi: 10.3389/fimmu.2022.1007165. eCollection 2022.
5
Analysis of Gut Microbiota in Rheumatoid Arthritis Patients: Disease-Related Dysbiosis and Modifications Induced by Etanercept.类风湿关节炎患者肠道微生物组分析:疾病相关的菌群失调和依那西普诱导的改变。
Int J Mol Sci. 2018 Sep 27;19(10):2938. doi: 10.3390/ijms19102938.
6
Triggers and regulation: the gut microbiome in rheumatoid arthritis.触发因素和调节:类风湿关节炎中的肠道微生物组。
Expert Rev Clin Immunol. 2023 Jul-Dec;19(12):1449-1456. doi: 10.1080/1744666X.2023.2260103. Epub 2023 Sep 15.
7
The role of microbiome in rheumatoid arthritis treatment.微生物群落在类风湿性关节炎治疗中的作用。
Ther Adv Musculoskelet Dis. 2019 Jul 30;11:1759720X19844632. doi: 10.1177/1759720X19844632. eCollection 2019.
8
Troublesome friends within us: the role of gut microbiota on rheumatoid arthritis etiopathogenesis and its clinical and therapeutic relevance.我们体内的麻烦朋友:肠道微生物群在类风湿性关节炎发病机制中的作用及其临床和治疗意义。
Clin Exp Med. 2021 Feb;21(1):1-13. doi: 10.1007/s10238-020-00647-y. Epub 2020 Jul 25.
9
Interactions between Gut Microbiota and Immunomodulatory Cells in Rheumatoid Arthritis.肠道微生物群与类风湿关节炎中免疫调节细胞的相互作用。
Mediators Inflamm. 2020 Sep 9;2020:1430605. doi: 10.1155/2020/1430605. eCollection 2020.
10
Pharmacomicrobiology of Methotrexate in Rheumatoid Arthritis: Gut Microbiome as Predictor of Therapeutic Response.甲氨蝶呤治疗类风湿关节炎的药物微生物组学:肠道微生物组作为治疗反应的预测因子。
Front Immunol. 2021 Dec 16;12:789334. doi: 10.3389/fimmu.2021.789334. eCollection 2021.

引用本文的文献

1
Immunomodulatory properties of the gut microbiome: diagnostic and therapeutic potential for rheumatoid arthritis.肠道微生物群的免疫调节特性:类风湿性关节炎的诊断和治疗潜力
Clin Exp Med. 2025 Jul 1;25(1):226. doi: 10.1007/s10238-025-01777-x.
2
Causal associations between gut microbiota and rheumatoid arthritis: A two-sample Mendelian randomization study.肠道微生物群与类风湿性关节炎之间的因果关联:一项两样本孟德尔随机化研究。
Medicine (Baltimore). 2025 May 30;104(22):e42596. doi: 10.1097/MD.0000000000042596.
3
A cross-sectional analysis of the vaginal microenvironment in rheumatoid arthritis.

本文引用的文献

1
Editorial: Disease-modifying antirheumatic drugs: Approaches and lessons learned from traditional medicine.社论:改善病情抗风湿药:传统医学的方法与经验教训
Front Pharmacol. 2023 Feb 3;14:1135803. doi: 10.3389/fphar.2023.1135803. eCollection 2023.
2
Rheumatoid Arthritis - Common Origins, Divergent Mechanisms.类风湿关节炎——共同起源,不同机制。
N Engl J Med. 2023 Feb 9;388(6):529-542. doi: 10.1056/NEJMra2103726.
3
Gut-joint axis: Gut dysbiosis can contribute to the onset of rheumatoid arthritis multiple pathways.肠道-关节轴:肠道菌群失调可通过多种途径导致类风湿关节炎的发病。
类风湿关节炎患者阴道微环境的横断面分析
medRxiv. 2025 Apr 13:2025.04.11.25325692. doi: 10.1101/2025.04.11.25325692.
4
Intestinal Permeability In Subjects With Rheumatoid Arthritis: A Critical Therapeutic Priority.类风湿关节炎患者的肠道通透性:一个关键的治疗重点。
Integr Med (Encinitas). 2024 Nov;23(5):16-26.
5
Current Approaches to Prevent or Reverse Microbiome Dysbiosis in Chronic Inflammatory Rheumatic Diseases.预防或逆转慢性炎症性风湿性疾病中微生物群失调的当前方法。
Mediterr J Rheumatol. 2024 Jun 30;35(2):220-233. doi: 10.31138/mjr.240224.cap. eCollection 2024 Jun.
6
Mechanisms and Clinical Implications of Human Gut Microbiota-Drug Interactions in the Precision Medicine Era.精准医学时代人类肠道微生物群与药物相互作用的机制及临床意义
Biomedicines. 2024 Jan 16;12(1):194. doi: 10.3390/biomedicines12010194.
Front Cell Infect Microbiol. 2023 Jan 27;13:1092118. doi: 10.3389/fcimb.2023.1092118. eCollection 2023.
4
ASPS Exhibits Anti-Rheumatic Effects by Reprogramming Gut Microbiota and Increasing Serum γ-Glutamylcysteine Level.ASPS 通过重编程肠道微生物群和增加血清 γ-谷氨酰半胱氨酸水平发挥抗风湿作用。
Adv Sci (Weinh). 2023 Jan;10(3):e2205645. doi: 10.1002/advs.202205645. Epub 2022 Nov 23.
5
The bone-protective mechanisms of active components from TCM drugs in rheumatoid arthritis treatment.中药活性成分在类风湿关节炎治疗中的骨保护机制
Front Pharmacol. 2022 Oct 25;13:1000865. doi: 10.3389/fphar.2022.1000865. eCollection 2022.
6
The bridge of the gut-joint axis: Gut microbial metabolites in rheumatoid arthritis.肠道-关节轴桥:类风湿关节炎中的肠道微生物代谢产物。
Front Immunol. 2022 Oct 6;13:1007610. doi: 10.3389/fimmu.2022.1007610. eCollection 2022.
7
Gut microbiota-derived metabolites in inflammatory diseases based on targeted metabolomics.基于靶向代谢组学的炎症性疾病中肠道微生物群衍生的代谢产物
Front Pharmacol. 2022 Sep 27;13:919181. doi: 10.3389/fphar.2022.919181. eCollection 2022.
8
Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities.肠道微生物群与类风湿关节炎:从发病机制到新的治疗机会。
Front Immunol. 2022 Sep 8;13:1007165. doi: 10.3389/fimmu.2022.1007165. eCollection 2022.
9
Collinsella is associated with cumulative inflammatory burden in an established rheumatoid arthritis cohort.科林斯氏菌与既定类风湿关节炎队列中的累积炎症负担有关。
Biomed Pharmacother. 2022 Sep;153:113518. doi: 10.1016/j.biopha.2022.113518. Epub 2022 Aug 6.
10
Stage-specific roles of microbial dysbiosis and metabolic disorders in rheumatoid arthritis.微生物群失调和代谢紊乱在类风湿性关节炎中的阶段特异性作用。
Ann Rheum Dis. 2022 Nov 10;81(12):1669-1677. doi: 10.1136/ard-2022-222871.